A recent Facebook study has initiated a debate on privacy and ethicis concerns, with the Federal Trade Commission saying they'll soon be involved as well.
Scholars are exhilarated by the prospect of tapping into the vast troves of personal data collected by Facebook, Google, Amazon and a host of start-ups, which they say could transform social science research.
Once forced to conduct painstaking personal interviews with subjects, scientists can now sit at a screen and instantly play with the digital experiences of millions of Internet users. It’s the frontier of social science — experiments on people who may never even know they are subjects of study, let alone explicitly consent.
“This is a new era,” said Jeffrey T. Hancock, a Cornell University professor of communication and information science. “I liken it a little bit to when chemistry got the microscope.”
Read the article here: http://nyti.ms/1lU8Hoo
Source: The New York Times
Dr Terrance Mayes and Dr Loretta Erhunmwunsee Discuss Leadership Roles for NCCN Forum on Equity
January 31st 2023Terrance Mayes, EdD, and Loretta Erhunmwunsee, MD, FACS, discuss their new roles as chair and vice-chair, respectively, of the National Comprehensive Cancer Network’s (NCCN) new Diversity, Equity, & Inclusion (DEI) Directors Forum.
Read More
Promoting Health Equity and Resiliency in Trauma-Affected Communities
January 31st 2023On this episode of Managed Care Cast, we speak with Reverend Paul Abernathy, CEO of the Neighborhood Resilience Project and board member of UPMC for You, who discusses his experiences in promoting health and resiliency in trauma-affected communities, as well as challenges related to access and accessibility of care and medical mistrust.
Listen
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
First Humira Biosimilar, Amjevita, Launches in the United States
January 31st 2023The first of at least 8 adalimumab biosimilars has finally launched in the United States after being kept off the market for years due to settlement agreements with the maker of the reference product, Humira.
Read More
2 Clarke Drive
Cranbury, NJ 08512